4-Liter Split-Dose Polyethylene Glycol Is Superior to Other Bowel Preparations, Based on Systematic Review and Meta-analysis Brintha K. Enestvedt, Christina Tofani, Loren A. Laine, Ann Tierney, M. Brian Fennerty Clinical Gastroenterology and Hepatology Volume 10, Issue 11, Pages 1225-1231 (November 2012) DOI: 10.1016/j.cgh.2012.08.029 Copyright © 2012 AGA Institute Terms and Conditions
Figure 1 Study selection for meta-analysis. *ClinicalTrials.gov and review of references from selected RCTs. Clinical Gastroenterology and Hepatology 2012 10, 1225-1231DOI: (10.1016/j.cgh.2012.08.029) Copyright © 2012 AGA Institute Terms and Conditions
Figure 2 Forest plot showing a significantly higher number of excellent or good bowel preparations with 4-L split-dose PEG. Clinical Gastroenterology and Hepatology 2012 10, 1225-1231DOI: (10.1016/j.cgh.2012.08.029) Copyright © 2012 AGA Institute Terms and Conditions
Figure 3 Post hoc subgroup meta-analyses showing a higher number of excellent or good bowel preparations with 4-L split-dose PEG than for (A) MiraLAX/Gatorade or (B) single-dose 4-L PEG preparations. (A) A 4-L split-dose PEG vs MiraLAX/Gatorade. (B) A 4-L split-dose PEG vs single-dose PEG. Clinical Gastroenterology and Hepatology 2012 10, 1225-1231DOI: (10.1016/j.cgh.2012.08.029) Copyright © 2012 AGA Institute Terms and Conditions
Figure 4 Funnel plot showing no significant publication bias for primary outcome. Clinical Gastroenterology and Hepatology 2012 10, 1225-1231DOI: (10.1016/j.cgh.2012.08.029) Copyright © 2012 AGA Institute Terms and Conditions